REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/01/2026
Back to search
Official data from USPTO
CHECKPOINT THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CHECKPOINT THERAPEUTICS
ST13
US500000087800976Class
5
Filing
87800976
Registration
6373293
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
06/02/2026
Trademark type
Word
Nice classes
5
Filing date
02/16/2018
Registration date
06/01/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2021
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/04/2017
First use in commerce
10/04/2017
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
AIKENS, RONALD E
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Checkpoint Therapeutics, Inc.
Representatives
Craig Kuchii
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicalbiological and pharmaceutical preparations for scientificresearchmedical or pharmaceutical usepreparations for the treatment of cancerlung diseases and tumors; Pharmaceutical preparations for the prevention and treatment of cancer; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Pharmaceutical productsagents in the form of powderscapsulescoatings for tablets for use in delivery of a wide range of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
44 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/03/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/27/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/26/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/24/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/23/2021
IUAF
USE AMENDMENT FILED
03/05/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/05/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/21/2020
EX4G
SOU EXTENSION 4 GRANTED
10/19/2020
EXT4
SOU EXTENSION 4 FILED
10/19/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/19/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/20/2020
EX3G
SOU EXTENSION 3 GRANTED
03/18/2020
EXT3
SOU EXTENSION 3 FILED
03/18/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/18/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/22/2019
EX2G
SOU EXTENSION 2 GRANTED
08/19/2019
EXT2
SOU EXTENSION 2 FILED
08/19/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/19/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/19/2019
EX1G
SOU EXTENSION 1 GRANTED
02/15/2019
EXT1
SOU EXTENSION 1 FILED
02/15/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/15/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/20/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/25/2018
PUBO
PUBLISHED FOR OPPOSITION
09/25/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2018
ALIE
ASSIGNED TO LIE
08/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/24/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/24/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/04/2018
GPRA
PRIORITY ACTION E-MAILED
06/04/2018
CPRA
PRIORITY ACTION WRITTEN
06/04/2018
DOCK
ASSIGNED TO EXAMINER
06/01/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2018
NWAP
NEW APPLICATION ENTERED
02/20/2018
Continuous trademark protection
Get notified about every new filing that threatens CHECKPOINT THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.